Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ: CGC ) saw their shares rise dramatically yesterday. As InvestorPlace's Shrey Dua reported, President Joe Biden's administration is moving to reschedule marijuana as a Schedule III substance.

Trade of the Day: Buy Canopy Growth (CGC) Stock Call Options on Rescheduling News

Aurora Cannabis

Cronos Group

Tilray Brands

Canopy Growth Corp. and Tilray Brands Inc. stocks made more modest moves on Wednesday after a huge rally in the previous session on plans by the Biden administration to reclassify pot as less dangerous under federal law.

Cannabis stocks settle down after rally on plans to reclassify pot as less dangerous

GrowGeneration Corp

Leafly Holdings

OrganiGram Holdings Inc.

Constellation Brands

Though there has never been a shortage of enthusiasm and interest in cannabis stocks, many of them have failed to take off, with some even dropping more than 90% from their initial public offering (IPO) price and turning into penny stocks.

The next pot of gold? Marijuana stocks surge higher on promise of reclassification

AdvisorShares Pure US Cannabis ETF

SNDL Inc.

Cannabis stocks have gone parabolic. Tilray Brands (TLRY) stock jumped by over 39% on Tuesday while Canopy Growth (CGC) soared by over 78%.

Here's the risk for buying TLRY, CGC, MSOS, and SNDL stocks

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

US plans to reclassify cannabis as less dangerous drug

American Homes 4 Rent

Cannabis company stocks skyrocketed Tuesday following multiple reports marijuana will be reclassified to a less dangerous drug schedule, which could broaden the substance's medical usage and cut down regulations tied to it.

Cannabis Stocks Spike Following Reports Marijuana Will Be Reclassified As Less Dangerous Drug

The DEA officially agreed to recommend rescheduling cannabis from a Class I to a Class III drug. While it doesn't legalize cannabis, the measure has the potential to be hugely impactful to U.S. multi-state operators.

Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

AdvisorShares Pure Cannabis ETF 

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

Cannabis stocks surged on Tuesday afternoon following multiple media reports that the US Drug Enforcement Administration will approve the reclassification of marijuana as a lower-risk drug. The news was first reported by the Associated Press, which cited five people familiar with the matter.

Cannabis stocks surge on reports DEA will approve rescheduling of marijuana as lower-risk drug

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Cambria Cannabis ETF

Roundhill Cannabis ETF

The Canadian cannabis industry is in a shakeout phase, with poorly run businesses struggling and the industry maturing.

Mario Naric On Canada's Shakeout Phase

Curaleaf Holdings, Inc.

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well.

3 Hot Cannabis Stocks With Multibagger Return Potential Before the Presidential Election

The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press reported on Tuesday, citing five people familiar with the matter.

US drug enforcers to ease restrictions on cannabis, AP reports

Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled substance. For more than 50 years, cannabis has been a Schedule I substance under federal law, in the same bucket as heroin and fentanyl.

Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA

Canopy Growth can move ahead with its plans to acquire U.S.-based cannabis companies via Canopy USA. The company, however, won't be able to consolidate the results.

Canopy Growth Obtains Shareholder Approval to Move Ahead With Canopy USA: Here's What It Means for Investors

The global cannabis industry and top marijuana stocks are poised for significant growth, driven by increasing legalization and medical use. Furthermore, experts predict a compound annual growth rate of over 20% for the next decade. Consequently, this expansion benefits top Canadian companies such as Canopy Growth, Aurora Cannabis, and Aphria. These firms lead the market in innovation and distribution. Therefore, investors should closely monitor these names, as they could capitalize on global trends.

Top Canadian Cannabis Contenders: Stocks to Watch Before May 2024

Trump Media & Technology Group Corp

GameStop

Nordstrom

Paramount Global

Express

If you're wondering what stocks to sell this quarter, you're in the right place. Nothing lasts forever, not even stocks.

7 Stocks That Could Be Heading Six-Feet Under

The cannabis industry has rapidly become a significant sector within the stock market, attracting a diverse array of investors. Yet marijuana stocks are notorious for their volatility, influenced heavily by regulatory changes and political dynamics. This article explores essential strategies for investing in cannabis stocks during these fluctuating conditions. Plus highlights how political developments can impact the way most marijuana stocks trade. Navigating the marijuana stock market requires savvy investment strategies that account for its inherent unpredictability.

Top Canadian Marijuana Stocks To Invest In For Big Gains

Marijuana legalization may be inching closer in the U.S. but it just became a reality in Germany. As of April 1, Germans can now legally grow up to three marijuana plants for personal use.

Cashing in on Cannabis: Why These 3 Weed Stocks Are Primed to Pop

Beyond Meat

QuantumScape

As concerns about a global recession grow, it might be wise to consider divesting from certain Nasdaq stocks to sell. The Nasdaq is known for hosting a range of innovative tech companies.

3 Nasdaq Stocks That Could Be Heading Six-Feet Under

Cannabis culture is being celebrated today on “4/20” with weed lovers gathering at events to partake in the plant and enjoy retail promotions.   While the history of 4/20 is disputed, most trace it back to a group of students who attended San Rafael High School in California in the 1970s.

4/20 2024: Cannabis investors have much to celebrate this year

Innovative Industrial Properties

IM Cannabis Corp

The progress toward legalization of cannabis in the United States continues at a slow pace, but medical marijuana is now permitted in approximately 37 states. Germany recently became the latest country to legalize cannabis for personal use beginning in April, coinciding with the informal holiday of 4/20.

Puff, Puff, Invest: 3 Top Cannabis Stock Picks to Celebrate 4/20

Alcoholic-beverage giant Constellation Brands Inc. on Thursday announced a number of moves intended to further distance itself from struggling Canadian cannabis producer Canopy Growth Corp., following a multibillion-dollar investment in the pot company several years ago.

Constellation Brands moves itself further away from cannabis grower Canopy Growth's business

Conversion of Greenstar Promissory Note into Exchangeable Shares further improves Canopy's balance sheet through the elimination of short term debt, reduces overall debt balance by C$100MM SMITHS FALLS, ON , April 18, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that in connection with the creation of the non-voting and non-participating exchangeable shares in the capital of Canopy Growth (the "Exchangeable Shares"), on April 18, 2024, Greenstar Canada Investment Limited Partnership ("Greenstar") and CBG Holdings LLC ("CBG" and, together with Greenstar, the "CBG Group"), each a wholly-owned subsidiary of Constellation Brands, Inc. ("CBI"), exchanged all 17,149,925 common shares in the capital of the Company (the "Common Shares") they collectively held for 17,149,925 Exchangeable Shares (the "CBI Exchange") for no consideration. As a result of the CBI Exchange, the CBG Group no longer holds any Common Shares.

Canopy Growth Announces CBI Conversion to Exchangeable Shares and Newly Constituted Board of Directors

Among the unlikely winners that are once again seeing strong interest in today's market, Canopy Growth (NASDAQ: CGC ) is on a tear. Shares of CGC stock are up a whopping 25% in early afternoon trading, prompting questions of whether this stock is due for a short squeeze.

Is a Short Squeeze Brewing in Canopy Growth (CGC) Stock?

News for Canopy Growth Stock (CGC)